ZR2 BIOENERGY (ZR2) | Financial Analysis & Statements
ZR2 BIOENERGY LIMITED Small-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
0
Gross Profit
-1.2M
Operating Income
-2.8M
Net Income
2.7M
EPS (Diluted)
₹0.06
Balance Sheet Metrics
Total Assets
1.4B
Total Liabilities
5.6M
Shareholders Equity
1.4B
Debt to Equity
0.00
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
ZR2 BIOENERGY Income Statement From 2024 to 2025
| Metric | 2025 | 2024 |
|---|---|---|
| Revenue | 14.9M | 15.7M |
| Cost of Goods Sold | 12.6M | 13.2M |
| Gross Profit | 2.4M | 2.5M |
| Gross Margin % | 16.0% | 16.0% |
| Operating Expenses | ||
| Research & Development | - | - |
| Selling, General & Administrative | 2.4M | 281.5K |
| Other Operating Expenses | 941.0K | 875.4K |
| Total Operating Expenses | 3.4M | 1.2M |
| Operating Income | -3.2M | 1.1M |
| Operating Margin % | -21.5% | 7.3% |
| Non-Operating Items | ||
| Interest Income | 4.9M | 2.4M |
| Interest Expense | 1.0K | 1.9M |
| Other Non-Operating Income | - | - |
| Pre-tax Income | 2.0M | 3.8M |
| Income Tax | 1.1M | -82.0K |
| Effective Tax Rate % | 55.3% | -2.2% |
| Net Income | 902.0K | 3.9M |
| Net Margin % | 6.0% | 24.7% |
| Key Metrics | ||
| EBITDA | 2.3M | 3.6M |
| EPS (Basic) | ₹0.25 | ₹1.24 |
| EPS (Diluted) | ₹0.02 | ₹1.24 |
| Basic Shares Outstanding | 3569000 | 3142620 |
| Diluted Shares Outstanding | 3569000 | 3142620 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
ZR2 BIOENERGY Balance Sheet From 2024 to 2025
| Metric | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Current Assets | ||
| Cash & Equivalents | 190.9M | 43.1M |
| Short-term Investments | 4.5M | 1.2M |
| Accounts Receivable | 236.0K | 18.6M |
| Inventory | - | 0 |
| Other Current Assets | 350.0K | 1.3M |
| Total Current Assets | 199.1M | 373.4M |
| Non-Current Assets | ||
| Property, Plant & Equipment | 5.0M | -10 |
| Goodwill | 0 | - |
| Intangible Assets | - | - |
| Long-term Investments | - | - |
| Other Non-Current Assets | 1.0K | -10 |
| Total Non-Current Assets | 1.2B | 18.8M |
| Total Assets | 1.4B | 392.2M |
| Liabilities | ||
| Current Liabilities | ||
| Accounts Payable | 861.0K | 56.1K |
| Short-term Debt | - | - |
| Current Portion of Long-term Debt | - | - |
| Other Current Liabilities | 501.0K | 2.9M |
| Total Current Liabilities | 1.6M | 3.6M |
| Non-Current Liabilities | ||
| Long-term Debt | - | 220.1M |
| Deferred Tax Liabilities | 9.0K | - |
| Other Non-Current Liabilities | - | -10 |
| Total Non-Current Liabilities | 9.0K | 220.1M |
| Total Liabilities | 1.6M | 223.7M |
| Equity | ||
| Common Stock | 3.6M | 3.6M |
| Retained Earnings | 29.8M | 28.9M |
| Treasury Stock | - | - |
| Other Equity | - | - |
| Total Shareholders Equity | 1.4B | 168.5M |
| Key Metrics | ||
| Total Debt | 0 | 220.1M |
| Working Capital | 197.5M | 369.8M |
Balance Sheet Composition
ZR2 BIOENERGY Cash Flow Statement From 2024 to 2025
| Metric | 2025 | 2024 |
|---|---|---|
| Operating Activities | ||
| Net Income | 2.0M | 3.8M |
| Depreciation & Amortization | - | - |
| Stock-Based Compensation | - | - |
| Working Capital Changes | 313.2M | -202.9M |
| Operating Cash Flow | 310.3M | -199.5M |
| Investing Activities | ||
| Capital Expenditures | -1.2B | 1.6M |
| Acquisitions | - | - |
| Investment Purchases | - | -65.4K |
| Investment Sales | - | 18.9M |
| Investing Cash Flow | -1.2B | 20.4M |
| Financing Activities | ||
| Share Repurchases | - | - |
| Dividends Paid | - | - |
| Debt Issuance | 802.8M | - |
| Debt Repayment | -220.1M | - |
| Financing Cash Flow | 1.8B | 120.9M |
| Free Cash Flow | -884.4M | -201.9M |
| Net Change in Cash | 922.1M | -58.2M |
Cash Flow Trend
ZR2 BIOENERGY Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
562.15
Price to Book
0.39
Price to Sales
2,694.93
PEG Ratio
-3.97
Profitability Ratios
Profit Margin
4,570.15%
Operating Margin
-52.51%
Return on Equity
0.06%
Return on Assets
0.06%
Financial Health
Current Ratio
36.02
Debt to Equity
0.00
Beta
0.42
Per Share Data
EPS (TTM)
₹0.27
Book Value per Share
₹392.10
Revenue per Share
₹0.06
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ZR2 | 514.6M | 562.15 | 0.39 | 0.06% | 4,570.15% | 0.00 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Ghcl | 46.2B | 9.54 | 1.33 | 17.89% | 16.60% | 2.66 |
| Styrenix Performance | 41.0B | 24.75 | 3.29 | 20.14% | 4.66% | 44.08 |
| Chemplast Sanmar | 38.6B | 210.40 | 2.02 | -5.34% | -7.01% | 96.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.





